Unicycive Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2020 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2020 to 2023.
  • Unicycive Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 88.9M shares, a 173% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 24.5M shares, a 63% increase from 2022.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.1M shares, a 29% increase from 2021.
  • Unicycive Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 11.7M shares, a 37.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 24.5M +9.48M +63% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 15.1M +3.38M +29% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 11.7M +3.18M +37.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 8.5M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.